top of page
Lab Worker


The Tessa Jowell Brain Cancer Mission is pleased to announce that the application round for the Tessa Jowell Fellowship programme is now open!

The Tessa Jowell Fellowship Programme is a training programme for medical specialties involved in the delivery of treatment, care and research for patients with brain tumours. It aims to create new attractive and rewarding career opportunities for aspiring scientists and clinicians in a challenging disease area, on the cusp of exciting and promising breakthroughs.

The Fellowships are the perfect launchpad for emerging talent to build a clinical career dedicated to helping patients with complex needs while also leading on cutting-edge research and innovation. The 12-month Fellowships are fully funded and aimed at exceptional applicants near to gaining their certificate of completion of training, who wish to further specialise in brain tumour treatment and research.

This year there are three fellowships available for neuro-oncology and neurology trainees near completion of training:   

  • Tessa Jowell Neuro-oncology Fellowship, co-funded by the Chief Scientist Office and Edinburgh/Glasgow (supervised by Prof Anthony Chalmers and Dr Faye Robertson) – Click here to apply (closes July 1 2024)

  • Tessa Jowell Neurology Fellowship, co-funded by NIHR and King’s Health Partners (supervised by Dr Gerald Finnerty) – Opening soon – Click here for more information (closes June 30 2024)

  • Tessa Jowell Drug Development Fellowship, co-funded by the NIHR and the Institute of Cancer Research/Royal Marsden (supervised by Dr Juanita Lopez ) – Opening soon – Click here for more information  (closes July 5 2024)

If you would like more information on the Fellowships, please contact

Collaborations & Opportunities: The Clinic
Data Analyst


Do you use clinical decision support systems?  

If so, please see the attached invitation below to participate in an interview study conducted by researchers from the University of Leeds, to explore the views of health professionals towards using data-driven clinical decision support tools in their clinical practice.

Background: Recent advances in technology, statistical and machine learning techniques, mean it is possible to analyse large quantities of data about multiple patients.  There are many new data-driven clinical decision support tools being developed using these techniques, but as yet only a few are available for clinical use.  Not much is known yet about how healthcare practitioners feel about using such tools, whether they trust them, or how useful they find them.

Approval: This study has been approved by the University of Leeds School of Medicine Research Ethics Committee, reference MREC 22-107.

Collaborations & Opportunities: The Clinic


The trainee members of the Clinical Oncology Academic Committee provide monthly email updates on external funding, fellowship and lectureship opportunities and relevant meetings and training courses in order to encourage the number and quality of research-active and academic Clinical Oncologists to members of the Clinical Oncology Trainee Research Network.

How to get involved

To register for your interest and subscribe to these monthly updates, click on the button below. 

Collaborations & Opportunities: The Clinic
Collaborations & Opportunities: The Clinic
Image by Dan Dimmock


Message from the UK ECRC December 2023

'We have exciting news to share regarding the future of our multidisciplinary community. In light of the NCRI winding down, we are thrilled to announce the relaunch of our forum as the UK Early Career Researchers in Cancer (UK ECRC) group!  🎉🎉🎉

Upcoming Opportunities!

We have been working hard behind the scenes to relaunch the forum and as we embark on this new chapter, we have some exciting opportunities lined up for our multidisciplinary members.

We are officially relaunching at the NOTCH Symposium in February next year, where we will have the chance to connect, share ideas, and explore new possibilities together!

We have been forging novel and exciting partnerships with national and international multidisciplinary organisations, which we will be updating you on very soon. This will lead to a plethora of future opportunities for our members.

Upcoming roles!

In the near future, we will be recruiting new positions within our committee and working groups.  Please watch this space! 👀 

What do I need to do to stay part of the group?

Nothing! You do not need to re-register to continue within the group, and it remains a free resource for ECRs across the UK.

Who and how can others join the group? 

Any multidisciplinary professionals with an interest in cancer research, who consider themselves early in their research career, can apply to join this group.  Please use the following link for new members to join: ✨ ✨

How to Stay Engaged? 💻

·      Follow us on X: @UKECRC

·      Contribute to upcoming opinion surveys – these will help us to help you and will help us identify engaged members to consider for committee roles!

·      Keep an eye on your inbox for updates and invitations to upcoming events.

·      Look out for our future networking platform, where you can connect with fellow members and stay informed about the latest news.

Your Data and Privacy

Your email address and the data you provided upon signing up (including your current role and research interests) have been obtained from the NCRI following full approval. We want to reassure you that we have sought advice from the Information Commissioner's Office (ICO), and your data is still being kept privately and securely.

What if I want to leave the group?

We understand your circumstances may have changed and we respect your privacy.  If you wish to opt out at any time, you can do so by clicking on

We are incredibly grateful for your continued support, and we look forward to the vibrant discussions and collaborations that lie ahead. If you have any questions or concerns, or want to get more involved in the group, please feel free to reach out.'



In July 2023, BioNTech signed a long-term partnership agreement with the UK, with the goal of working together to develop new cancer therapies for the benefit of NHS patients. This includes an accelerated clinical trials program supported by NIHR and NHS England, agreeing to deliver 10,000 cancer vaccines to patients in the UK by 2030. BioNTech have a diverse portfolio of trials in cancer vaccines and next generation immunotherapies, currently being brought to the UK. With this in mind, it is an exciting time to be involved in these latest technologies and trials and this role offers a unique opportunity to be at the forefront of the national cancer vaccine advance.

BioNTech are expanding their UK team and it is an exciting time to be involved in the national cancer vaccine advance. Research interest and experience is important, and whilst previous industry experience is a bonus it is certainly not required. The role as a medical science liaison includes serving as the link between trial investigators and BioNTech, but also supporting global trials teams with activities from clinical development and early protocol discussion, to overseeing regulatory approvals and inputting on general strategy for the UK partnership and initiatives such as the Cancer Vaccine Launchpad.

This role is primarily remote, and ideal as an out of programme experience for medical or clinical oncologists. Duration is flexible, but a minimum of 1 year (2-3 years recommended.)

If interested, please contact

Collaborations & Opportunities: The Clinic
bottom of page